Cell-specific genetic medicines
Company is active
Event Year: 2021
Company is active
Event Year: 2021
Nuntius Therapeutics is dedicated to pioneering the development of cell-specific genetic medicines. Their focus lies in creating targeted therapies that precisely address diseases at the cellular level, potentially revolutionizing treatment approaches and improving patient outcomes. By engineering genetic medicines to target specific cell types, Nuntius aims to enhance efficacy and minimize off-target effects, leading to more effective and safer treatments for a range of diseases.
Nuntius Therapeutics is dedicated to pioneering the development of cell-specific genetic medicines. Their focus lies in creating targeted therapies that precisely address diseases at the cellular level, potentially revolutionizing treatment approaches and improving patient outcomes. By engineering genetic medicines to target specific cell types, Nuntius aims to enhance efficacy and minimize off-target effects, leading to more effective and safer treatments for a range of diseases.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2021
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2021
Healthcare
Healthcare
Healthcare -> Therapeutics
Healthcare -> Therapeutics
Team size: 2
Hiring: No
Team size: 2
Hiring: No